510(k) Report

PMA · Approved

Approved

Onyx Liquid Embolic System

P030004PMAApproved Jul 21, 2005856-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ev3 Neurovascular · MFE Agent, Injectable, Embolic

Approved on Jul 21, 2005 through premarket approval, which rests on the device’s own clinical evidence after an 856-day review.

Decided
Jul 21, 2005
Review
856 days
Class
Class III
Product code
MFE
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P030004 has 41 supplements since 2006: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2006: 22007: 12012: 12013: 22014: 12015: 12016: 22017: 22018: 32019: 52020: 42021: 32022: 12023: 12024: 52025: 12026: 6
2006high 6 (2026) · low 0 (2008)2026
View FIG. 1 as a table
YearSupplements approved
20062
20071
20121
20132
20141
20151
20162
20172
20183
20195
20204
20213
20221
20231
20245
20251
20266
FIG. 1 — Supplements to P030004, 2006–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MFE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MFE devices

MFE Agent, Injectable, Embolic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MFE

5in 2024

2007: 12012: 12013: 22014: 12015: 12016: 22017: 22018: 32019: 52020: 42021: 32022: 12023: 12024: 52026 (partial year): 5
2007high 5 (2019) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MFE

Too few MFE 510(k)s in any year since 2007 to give a median.

Recalls per year · MFE

No recall names MFE since 2007.

Adverse event reports per year · MFE

177in 2025

2007: 182008: 612009: 562010: 852011: 972012: 612013: 822014: 732015: 2382016: 2212017: 3652018: 1192019: 1192020: 1242021: 1502022: 1762023: 4332024: 2482025: 177
2007high 433 (2023) · low 18 (2007)2025

MAUDE reports naming product code MFE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—018
20080—061
20090—056
20100—085
20110—097
20121—061
20132—082
20141—073
20151—0238
20162—0221
20172—0365
20183—0119
20195—0119
20204—0124
20213—0150
20221—0176
20231—0433
20245—0248
20250—0177
20265—0—
Cite this page

510(k) Report. “P030004: Onyx Liquid Embolic System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P030004

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026